Evidence map›Paper›PMID 31620093›Full record

ArticleFrontiers in endocrinology2019

Glucose Increase DAGLα Levels in Tanycytes and Its Inhibition Alters Orexigenic and Anorexigenic Neuropeptides Expression in Response to Glucose.

Alejandra Palma-Chavez, Macarena Konar-Nié, Patricio Órdenes, Felipe Maurelia, Roberto Elizondo-Vega, Karina Oyarce, Sergio López, Joaquin Rojas, Ximena Steinberg, María A García-Robles and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?International journal of molecular sciences · 2023
    Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alejandra Palma-ChavezLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Macarena Konar-NiéLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Patricio ÓrdenesLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Felipe MaureliaLaboratorio de Bioquímica y Biología Celular, Departamento de Bioquímica y Biología Molecular, Universidad de Concepción, Concepción, Chile.
Roberto Elizondo-VegaLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Karina OyarceFacultad de Medicina y Ciencia, Universidad San Sebastián, Concepción, Chile.
Sergio LópezLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Joaquin RojasCentro de Estudios Avanzados para la Vida (CREAV), Universidad de Concepción, Concepción, Chile.
Ximena SteinbergLaboratorio de Bioquímica y Biología Celular, Departamento de Bioquímica y Biología Molecular, Universidad de Concepción, Concepción, Chile.
María A García-RoblesLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.
Fernando J SepúlvedaLaboratorio de Biología Celular, Departamento de Biología Celular, Universidad de Concepcion, Concepción, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endocannabinoid system (ECS) is composed of a group of Gi-coupled protein receptors and enzymes, producing and degrading the endocannabinoids, 2-arachidonoylglycerol (2-AG) and N-arachidonoyl-ethanolamine (AEA). Endocannabinoid-mediated signaling modulates brain functions, such as pain, mood, memory, and feeding behavior. The activation of the ECS is associated with overeating and obesity; however, the expression of components of this system has been only partially studied in the hypothalamus, a critical region implicated in feeding behavior. Within this brain region, anorexigenic, and orexigenic neurons of the arcuate nucleus (ARC) are in close contact with tanycytes, glial radial-like cells that line the lateral walls and floor of the third ventricle (3V). The specific function of tanycytes and the effects of metabolic signals generated by them on adjacent neurons is starting to be elucidated. We have proposed that the ECS within tanycytes modulates ARC neurons, thus modifying food intake. Here, we evaluated the expression and the loss of function of the 2-AG-producing enzyme, diacylglycerol lipase-alpha (DAGLα). Using Western blot and immunohistochemistry analyses in basal hypothalamus sections of adult rats under several glycemic conditions, we confirm that DAGLα is strongly expressed at the basal hypothalamus in glial and neuronal cells, increasing further in response to greater extracellular glucose levels. Using a DAGLα-inhibiting adenovirus (shRNA), suppression of DAGLα expression in tanycytes altered the usual response to intracerebroventricular glucose in terms of neuropeptides produced by neurons of the ARC. Thus, these results strongly suggest that the tanycytes could generate 2-AG, which modulates the function of anorexigenic and orexigenic neurons.

Indexed as

DAGLαendocannabinoid systemfeeding behaviorhypothalamusTanycytes

Identifiers

PMID31620093
PMCPMC6763563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.